With more than ten years of time-consuming and laborious efforts in manifesting the functions and safety, we proudly announce that our NEW red yeast rice extract (ANKASCIN 568-R) has been approved by the US FDA as an NEW DIETARY INGREDIENT (NDI, report # 855).
For the past nearly 20 years, ANKASCIN 568-R has been proven by 120+ publications to be effective in managing blood lipids, blood sugar, blood pressure, and improving symptoms of Alzheimer’s disease through many animal tests conducted by Professor Tzu-Ming Pan from National Taiwan University, Taiwan.
Interview from PharmaBoardRoom: George J. Lee, Ph.D. – Chairman; Tzu-Ming Pan, Ph.D – Vice Chairman and Chief Technology and Science Officer, SunWay Biotech, Taiwan
George Lee and Tzu-Ming Pan introduce SunWay Biotech’s groundbreaking red yeast rice extract, ANKASCIN® 568-R, which has been recognized as a New Dietary Ingredient by the US FDA. SunWay Biotech is now bringing this unique product onto the global stage and are considering developing a pharmaceutical product based on the same compounds.